News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Loop Capital starts coverage of Vertiv with a Buy rating and $500 target, citing rising AI data-center demand.
  • Evercore initiates coverage of J.M. Smucker with Outperform and $117 target, flagging coffee margin improvement and cost savings.
  • Institutional investors increased positions in publicly traded private-credit funds in Q1, signaling continued institutional demand despite softer returns.
  • MacKenzie Realty posts Q3 results with net revenue up 27% and positive FFO as Aurora leasing exceeds 90%.
  • FAA lowers air-traffic controller staffing goal to 12,563 from 14,633 amid rising overtime costs and scheduling inefficiencies.
  • CDC is tracking Ebola outbreaks in the DRC and Uganda and providing technical support to local health authorities.
  • Geo Group shares slipped after a California DOJ report cited worsening detention conditions, medical shortfalls, and multiple deaths.

Latest Articles

Bessent Defends Fed Independence, Flags Stablecoins as Potential Treasury Tool

Bessent Defends Fed Independence, Flags Stablecoins as Potential Treasury Tool

Treasury Secretary Bessent told the House Financial Services Panel that Federal Reserve independence is essential to effective monetary policy, urging the central bank to stay within its core mandate. He acknowledged a loss of public trust during the inflation episode, cautioned against chasing a 'zero-risk financial system,' and signaled support f…

Canada Aims to Reassert Itself Against U.S. in Renewed Olympic Ice Hockey Rivalry

Canada Aims to Reassert Itself Against U.S. in Renewed Olympic Ice Hockey Rivalry

Defending Olympic women's ice hockey champions Canada arrive in Milano Cortina determined to respond to recent heavy defeats by the United States. Despite a four-game sweep in the Rivalry Series and earlier World Championship loss to their neighbours, Canada’s roster—featuring a large contingent of veterans and players from the PWHL—enters the Game…

Copenhagen benchmark tumbles as healthcare and tech drag stocks lower

Copenhagen benchmark tumbles as healthcare and tech drag stocks lower

Shares in Denmark finished lower on Wednesday, led by declines in the Healthcare, Technology and Oil & Gas sectors. The OMX Copenhagen 20 dropped 6.66% to a fresh one-month low. While a handful of large-cap names advanced, several heavyweight stocks posted significant losses. Commodities and currency markets showed modest moves, with oil and gold e…

Buy the Dip, Collect the Dividend - A Tactical HCI Group Swing

Buy the Dip, Collect the Dividend - A Tactical HCI Group Swing

HCI Group (HCI) offers a constructive risk/reward: robust free cash flow, low leverage, and an upcoming dividend plus Exzeo IPO optionality set up a mid-term (45 trading days) swing trade. Valuation is compelling at roughly a 10x P/E and EV/EBITDA ~3.6. Enter near current levels, keep a tight stop under structural support, and target a re-rate towa…

UBS Raises DaVita Target to $190, Cites Elevated 2026 EPS Outlook

UBS Raises DaVita Target to $190, Cites Elevated 2026 EPS Outlook

UBS increased its price objective for DaVita to $190 from $186 and kept a Buy rating after the company provided 2026 guidance showing robust adjusted EPS growth at the midpoint. Recent quarterly results beat expectations and management activity, including share repurchases and a planned strategic investment, are cited as contributors to near-term e…

Analysis: Paid crypto press releases heavily tied to high-risk and fraudulent projects, Chainstory finds

Analysis: Paid crypto press releases heavily tied to high-risk and fraudulent projects, Chainstory finds

A Chainstory analysis of roughly 2,900 cryptocurrency press releases published over a four-month span found that about 62% originated from projects labeled high risk or fraudulent. The study highlights a pay-to-play distribution model, heavy use of promotional language, and a concentration of dubious issuers in sectors such as cloud mining and frin…

UBS Boosts FedEx Price Target to $412, Cites Pricing Levers and Cost Cuts

UBS Boosts FedEx Price Target to $412, Cites Pricing Levers and Cost Cuts

UBS raised its price target on FedEx to $412 from $314 and reaffirmed a Buy rating, citing stronger-than-expected pricing power and cost-control prospects. The new target implies meaningful upside from the stock's recent trading level near $363 and close to its 52-week high. Separately, Bernstein SocGen Group upgraded the stock and lifted its targe…

U.S. Gasoline Inventories Climb to Highest Level Since June 2020

U.S. Gasoline Inventories Climb to Highest Level Since June 2020

The Energy Information Administration's weekly Petroleum Status Report shows U.S. gasoline inventories increased by 685,000 barrels to 257.9 million barrels for the week ended January 30, reaching the highest level recorded since June 2020. The same report records the largest week-over-week decline in distillate stockpiles since February 2021, with…

DA Davidson Cuts Yext Price Target After CEO Withdraws $9 Buyout Proposal

DA Davidson Cuts Yext Price Target After CEO Withdraws $9 Buyout Proposal

DA Davidson reduced its price target for Yext Inc. to $6.00 from $8.25 while leaving a Neutral rating in place, after Yext shares slid and CEO Michael Walrath withdrew a $9.00-per-share proposal to buy the remaining outstanding stock. The firm’s new valuation implies a 1.6x EV/Sales multiple on its fiscal 2027 estimates. Separately, Yext posted fis…

Wolfe Research Urges Buying Celcuity on Any Post-Catalyst Weakness

Wolfe Research Urges Buying Celcuity on Any Post-Catalyst Weakness

Wolfe Research recommends investors buy Celcuity (CELC) shares on any pullbacks tied to an external catalyst, while warning against directly extrapolating prior giredestrant results to the persevERA study. The stock, trading at $105.84, has surged 787.29% over the past year and is nearing its 52-week high of $120.31. Separately, the FDA has accepte…